Highlighting the new consensus guidelines for managing people at risk of, and with early-stage type 1 diabetes-Relevance to clinical care in the UK

Parth Narendran; Philip Newland-Jones; Naresh Kanumilli; Rose Stewart; Fiona Regan; Tabitha Randell

doi:10.1111/dme.15508

Highlighting the new consensus guidelines for managing people at risk of, and with early-stage type 1 diabetes-Relevance to clinical care in the UK

Parth Narendran^*
, Philip Newland-Jones
, Naresh Kanumilli
, Rose Stewart
, Fiona Regan
, Tabitha Randell

^*Corresponding author for this work

Immunology and Immunotherapy

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	e15508
Number of pages	3
Journal	Diabetic Medicine
Volume	42
Issue number	6
Early online date	29 Dec 2024
DOIs	https://doi.org/10.1111/dme.15508
Publication status	Published - Jun 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1111/dme.15508Licence: Creative Commons: Attribution (CC BY)

Cite this

@article{625c0fe2e84e4734a7d4f8beeb82db37,

title = "Highlighting the new consensus guidelines for managing people at risk of, and with early-stage type 1 diabetes-Relevance to clinical care in the UK",

author = "Parth Narendran and Philip Newland-Jones and Naresh Kanumilli and Rose Stewart and Fiona Regan and Tabitha Randell",

year = "2025",

month = jun,

doi = "10.1111/dme.15508",

language = "English",

volume = "42",

journal = "Diabetic Medicine",

issn = "0742-3071",

publisher = "Wiley",

number = "6",

}

TY - JOUR

T1 - Highlighting the new consensus guidelines for managing people at risk of, and with early-stage type 1 diabetes-Relevance to clinical care in the UK

AU - Narendran, Parth

AU - Newland-Jones, Philip

AU - Kanumilli, Naresh

AU - Stewart, Rose

AU - Regan, Fiona

AU - Randell, Tabitha

PY - 2025/6

Y1 - 2025/6

U2 - 10.1111/dme.15508

DO - 10.1111/dme.15508

M3 - Article

C2 - 39733443

SN - 0742-3071

VL - 42

JO - Diabetic Medicine

JF - Diabetic Medicine

IS - 6

M1 - e15508

ER -